STRATAGEM: Strategy for Managing Antiplatelet Therapy in the Perioperative Period of Non Coronary Surgery
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The STRATAGEM trial is an investigator-driven French nationwide multicenter, randomized,
double-blind, placebo-controlled trial comparing perioperative low-dose aspirin therapy
versus placebo in the perioperative period in patients with documented symptomatic stable
atherothrombotic disease taking antiplatelet therapy and undergoing non-coronary surgery.